Efficacy of Fenretinide at Regressing CIN 6 months [clinicaltrials_resource:88d3eb6b2d0c215bb5da59c7ffee90ff]
Oral Fenretinide daily for 6 months with 3 days of rest every month.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Efficacy of Fenretinide at Regressing CIN 6 months [clinicaltrials_resource:88d3eb6b2d0c215bb5da59c7ffee90ff]
Oral Fenretinide daily for 6 months with 3 days of rest every month.
Bio2RDF identifier
88d3eb6b2d0c215bb5da59c7ffee90ff
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:88d3eb6b2d0c215bb5da59c7ffee90ff
measure [clinicaltrials_vocabulary:measure]
Efficacy of Fenretinide at Regressing CIN
time frame [clinicaltrials_vocabulary:time-frame]
description
Oral Fenretinide daily for 6 months with 3 days of rest every month.
identifier
clinicaltrials_resource:88d3eb6b2d0c215bb5da59c7ffee90ff
title
Efficacy of Fenretinide at Regressing CIN 6 months
@en
type
label
Efficacy of Fenretinide at Reg ...... 3eb6b2d0c215bb5da59c7ffee90ff]
@en